Herborium Group Commences AcnEase(R) Retail Sales
June 02 2010 - 4:00PM
Marketwired
Herborium Group, Inc., (PINKSHEETS: HBRM), a Botanical
Therapeutics™ company, today announced it has now successfully
secured direct consumer points-of-sale for its flagship product,
AcnEase®, with a recognized group of New York dermatological
clinics.
"Acceptance of AcnEase by board certified dermatologist to be
sold in the clinics is a major third-party validation of the
therapeutic value of our product, and is an important cornerstone
in building the AcnEase® brand," commented Dr. Agnes P. Olszewski,
Herborium Group's president and chief executive officer.
AcnEase® is a proprietary, all herbal, systemically acting
botanical therapeutic targeting acne symptom in both females and
males of all ages, and has been proven safe and effective through
clinical testing. Test results have demonstrated that in adolescent
acne, approximately 95% of patients responded positively to
AcnEase. In individuals above age 31, the level of effectiveness
was 80%. The overall positive response rate to AcnEase was 91%.
After more than five years of online sales, Herborium has
consistently registered over 95% consumer satisfaction rating
(www.acnease.com).
Dr. Olszewski continued, "Expanding beyond e-commerce (internet
sales) to direct consumer points-of-sale is an important milestone
in our overall plan to increase AcnEase sales and brand recognition
and grow market share within the US 3.5 billion over the counter
medicated skin care market
"With the current surge in sales of over-the-counter nutritional
and health supplements, combined with Hoffmann-La Roche Inc.'s
announcement to discontinue marketing of its leading treatment for
severe acne, Accutane® (isotretinoin), and Herborium's AcnEase
product's demonstrated and documented over five year history of
safe and effective acne treatment, I firmly believe we have the
right product, at the right time, for over 50 million acne
sufferers in the USA.
"Having successfully launched our direct-to-consumer sales
strategy with AcnEase in the US market , we intend to replicate
this strategy to the extent justified "by market conditions" in
International markets, while we prepare our next product sales
initiative to access the US cosmeceutical market expected to
potentially reach over $16 billion by 2010.
"Herborium is committed to continue developing a global brand
with a strong international distribution network, and the
acceptance of AcnEase by the dermatological community is a key
development in both product branding and sales growth strategies,"
Dr. Olszewski concluded.
About Herborium Group, Inc.
Herborium Group, Inc., a botanical therapeutics® company,
focuses on developing, licensing, and marketing proprietary,
botanical based medicinal products to consumers and healthcare
professionals. The Company business model focuses on emerging
market opportunities spearheaded by the growth of a new market
sector located between high-cost, high-risk, ethical
pharmaceuticals and commoditized classic nutraceuticals
(supplements). The Company uses clinical validation and a proactive
regulatory strategy based on the FDA Guidance for Industry:
Botanical Drug Products (FDA Guidance 2004) to establish and
maintain a differential advantage. Herborium harvests its
therapeutic candidates from Traditional Chinese Medicine and
utilizes Western regulatory, clinical and marketing strategies to
successfully introduce the products to the Western markets. The
company secured a pipeline of botanical ingredients based products
in the areas of dermatological needs, Prostate Health (BPH), Liver
Diseases, Women's Health and selected sexual disorders resulting
from cardiovascular disease, use of anti-depressants, surgical
procedures, and other problems. Herborium Group sells its products
in the United States, the United Kingdom, and continental Europe
through a network of distributors, specialty retailers, and
e-commerce.
One of our most important responsibilities is to communicate
with shareholders in an open and direct manner. Comments are based
on current management expectations, and are considered
"forward-looking statements," generally preceded by words such as
"plans," "expects," "believes," "anticipates," or "intends." We
cannot promise future returns. Our statements reflect our best
judgment at the time they are issued, and we disclaim any
obligation to update or alter forward-looking statements as the
result of new information or future events. Adino Energy
Corporation urges investors to review the risks and uncertainties
contained within its filings with the Securities and Exchange
Commission.
Company Contact: Dr. Agnes P. Olszewski President &
CEO (201) 647-3757
Herborium (PK) (USOTC:HBRM)
Historical Stock Chart
From May 2024 to Jun 2024
Herborium (PK) (USOTC:HBRM)
Historical Stock Chart
From Jun 2023 to Jun 2024